[HTML][HTML] CA125 and ovarian cancer: a comprehensive review
Simple Summary CA125 has been the most promising biomarker for screening ovarian
cancer; however, it still does not have an acceptable accuracy in population-based …
cancer; however, it still does not have an acceptable accuracy in population-based …
[HTML][HTML] CA125 and Ovarian Cancer: A Comprehensive Review
P Charkhchi, C Cybulski, J Gronwald, FO Wong… - Cancers, 2020 - ncbi.nlm.nih.gov
Ovarian cancer is the second most lethal gynecological malignancy. The tumour biomarker
CA125 has been used as the primary ovarian cancer marker for the past four decades. The …
CA125 has been used as the primary ovarian cancer marker for the past four decades. The …
[PDF][PDF] CA125 and Ovarian Cancer: A Comprehensive Review
P Charkhchi, C Cybulski, J Gronwald, FO Wong… - pdfs.semanticscholar.org
Ovarian cancer is the second most lethal gynecological malignancy. The tumour biomarker
CA125 has been used as the primary ovarian cancer marker for the past four decades. The …
CA125 has been used as the primary ovarian cancer marker for the past four decades. The …
[PDF][PDF] CA125 and Ovarian Cancer: A Comprehensive Review
P Charkhchi, C Cybulski, J Gronwald, FO Wong… - scienceopen.com
Ovarian cancer is the second most lethal gynecological malignancy. The tumour biomarker
CA125 has been used as the primary ovarian cancer marker for the past four decades. The …
CA125 has been used as the primary ovarian cancer marker for the past four decades. The …
CA125 and Ovarian Cancer: A Comprehensive Review
P Charkhchi, C Cybulski, J Gronwald, FO Wong… - tspace.library.utoronto.ca
Ovarian cancer is the second most lethal gynecological malignancy. The tumour biomarker
CA125 has been used as the primary ovarian cancer marker for the past four decades. The …
CA125 has been used as the primary ovarian cancer marker for the past four decades. The …
[PDF][PDF] CA125 and Ovarian Cancer: A Comprehensive Review
P Charkhchi, C Cybulski, J Gronwald, FO Wong… - ppm.edu.pl
Ovarian cancer is the second most lethal gynecological malignancy. The tumour biomarker
CA125 has been used as the primary ovarian cancer marker for the past four decades. The …
CA125 has been used as the primary ovarian cancer marker for the past four decades. The …
CA125 and Ovarian Cancer: A Comprehensive Review
P Charkhchi, C Cybulski, J Gronwald, FO Wong… - Cancers, 2020 - cir.nii.ac.jp
抄録< jats: p> Ovarian cancer is the second most lethal gynecological malignancy. The
tumour biomarker CA125 has been used as the primary ovarian cancer marker for the past …
tumour biomarker CA125 has been used as the primary ovarian cancer marker for the past …
CA125 and Ovarian Cancer: A Comprehensive Review
P Charkhchi, C Cybulski, J Gronwald, FO Wong… - search.proquest.com
Ovarian cancer is the second most lethal gynecological malignancy. The tumour biomarker
CA125 has been used as the primary ovarian cancer marker for the past four decades. The …
CA125 has been used as the primary ovarian cancer marker for the past four decades. The …
CA125 and Ovarian Cancer: A Comprehensive Review.
P Charkhchi, C Cybulski, J Gronwald, FO Wong… - Cancers, 2020 - europepmc.org
Ovarian cancer is the second most lethal gynecological malignancy. The tumour biomarker
CA125 has been used as the primary ovarian cancer marker for the past four decades. The …
CA125 has been used as the primary ovarian cancer marker for the past four decades. The …
CA125 and Ovarian Cancer: A Comprehensive Review
P Charkhchi, C Cybulski, J Gronwald, FO Wong… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Ovarian cancer is the second most lethal gynecological malignancy. The tumour biomarker
CA125 has been used as the primary ovarian cancer marker for the past four decades. The …
CA125 has been used as the primary ovarian cancer marker for the past four decades. The …